This special issue covers a range of recent and significant topics in Medicinal Chemistry, including host-guest interactions, advancements in drug discovery, synthesis and application of bioactive molecules, and treatments for neglected diseases. Additionally, it explores computational methods applied to Medicinal Chemistry, the importance of natural products, and the role of multicomponent reactions in synthesis. Medicinal Chemistry plays a vital role in improving human health and requires extensive interdisciplinary efforts. In the face of challenges to scientific understanding and acceptance, the resilience of medicinal chemists offers hope for the future, underscoring the need for ongoing support and investment in this field. Read more at Editorial.
Special Issue Medicinal Chemistry

									Brenno A. D. Neto 
; Carlos Mauricio R. Sant'Anna
								
									Guilherme S. Caleffi 
; Alcides J. M. da Silva 
; Chaquip Daher Netto 
; Jorge L. O. Domingos 
; Eduardo J. Salustiano 
; 
Paulo R. R. Costa 
								
									
									Modified flavonoids were synthesized and showed potent antiproliferative and antiparasitic activity in vitro and in vivo, and antiviral activity in vitro.
									Lucas S. Franco; Rodolfo C. Maia; Eliezer J. Barreiro 
								
									
									This account describes the LASSBio Chemical Library diversity and a virtual screening against feline McDonough sarcoma-like tyrosine kinase 3 (FLT3).
									Cláudio E. Rodrigues-Santos 
; Maurício R. de Brito; Aurea Echevarria 
								
									
									Mini review highlighting amidine derivatives: principal synthesis methods and anti-Leishmania activity results.
									Saulo T. Abreu 
; Luis Gabriel V. Gelves 
; Eliezer J. Barreiro 
; Lídia M. Lima
								
									
									Nitroaromatic as drug: Food and Drug Administration (FDA) approval, mechanisms of bioactivation, metabolism and toxicity, and synthesis of nitroaromatic fragment by nitration and amine oxidation.
									Henrique B. de Lima 
; Gustavo M. das Neves 
; Itamar L. Gonçalves 
; Aloir A. Merlo 
; Vera L. Eifler-Lima
								
									
									A bibliometric analysis was performed to map the research performed in Brazil on multicomponent reactions over a period of 30 years through a literature search.
									Afonso S. M. M. Velez 
; Paulo Pitasse-Santos 
; Leonardo Freire-de-Lima 
; Célio G. Freire-de-Lima 
; Debora Decoté-Ricardo 
; Marco E. F. de Lima
								
									
									Piperine is a natural amide with an interesting chemical structure and promising activities against several parasitic diseases. It is a renewable natural product easily extracted from black pepper, one of the most important spices used worldwide.
									Thayná A. Bibiano; Heber Victor Tolomeu 
; Pedro S. M. Pinheiro 
; Carlos Alberto M. Fraga
								
									
									Enhancing the equilibrium between promiscuous and privileged structures in Medicinal Chemistry.
									Lucas S. Franco 
; Pedro S. M. Pinheiro 
; Maria Letícia C. Barbosa
								
									
									This article reviews the synthesis and biological activities of the amino-quinazoline privileged structure over the last 30 years, focusing on the last decade.
									Pamella C. C. da Silva 
; Leandro Martínez
								
									
									A bibliographical review of molecular dynamics enhanced sampling techniques for analysis of Plasmodium falciparum proteins and their implications for antibody binding.
									Vinícius N. Rocha; Carlos M. R. Sant'Anna
								
									
									The image shows the evolution in the usage of Computer-Assisted Drug Design (CADD) methods during the last 30 years.
									
									Metallocenes, "half sandwich" M-arenes and metal carbonyls are potential drugs against malaria and neglected diseases caused by trypanosomatid parasites and parasitic helminths.
									Júlia G. B. Pedreira 
; Stefan Laufer
								
									
									This work reviews protein kinase inhibitors of the last 30 years and highlights contributions from Brazilian researchers.
									
									The advancements in both chemistry and the biological behavior, with a focus on boron neutron capture therapy involving specific polyhedral boron clusters, are examined.
									Adenilson G. Lima; André B. Penteado; Jullyane G. de Jesus; Vanessa J. R. de Paula; Witor R. Ferraz 
; Gustavo H. G. Trossini
								
									
									Workflow diagram of a structure-based virtual screening (SBVS) process showing the two approaches discussed in this work.
									Gabriel Jasinski; María Florencia Martini; Albertina G. Moglioni
								
									
									This review presents the main developments in inhibitors of cruzipain/cruzain, a crucial enzyme in the life cycle of Trypanosoma cruzi, the etiological agent of Chagas disease, from the 1990s to the present.
									Hugo Verli 
; Chris Oostenbrink
								
									
									Evolution of molecular simulations applications in drug-discovery in the past 30 years.
									Julieth G. Herrera 
; Larissa A. Rolim 
; Ricardo S. Honorato 
; Maria Fernanda Pimentel
								
									
									Chromatographic techniques and alternative strategies for qualitative and quantitative analysis of cannabinoids in medicinal cannabis products and cannabis extracts.
									Mikaela L. de Souza; Graziella R. R. Franco; Larissa E. Massuda; Vanessa S. Gontijo; Claudio Viegas Jr.
								
									
									Cannabidiol (CBD) and its synthetic derivatives and analogues have been investigated for decades due to their medicinal uses as neuroprotective, anti-convulsive, antinociceptive, and anti-inflammatory, aimed at clarifying the mechanisms of action underlying their pharmacology and contribute to the development of innovative drugs.
									Fernanda Bongiovani; Marcos A. Ferreira-Junior 
; Soraya S. Santos 
; Jeanine G. Vargas 
; Elizabeth I. A. Ferreira
								
									
									Relationship between drug repositioning, artificial intelligence with essential participation of human beings, generating molecules which could turn into medicines.
									Lucas Caruso 
; Thiago M. Pereira 
; Arthur E. Kümmerle
								
									
									How much PROTACs (protheolysis targeting chimeras) can change the drug discovery? Since its discovery in 2001, a huge evolution has been done in terms of mechanisms, proof of concepts and design. A new PROTAC drug can be one step from the market, with ARV-471 that just entered in phase III clinical trials.
									Thamires Q. Froes 
; Marcelo S. Castilho
								
									
									Localized protein frustration is higher around druggable hotspots, partially explaining their origin and suggesting innovative hit-to-lead strategies.
									Romulo C. Ferreira; Otávio Augusto Chaves 
; Cosme Henrique C. S. de Oliveira; Vitor Francisco Ferreira 
; Sabrina B. Ferreira; Carlos Serpa; Dari Cesarin-Sobrinho; José Carlos Netto-Ferreira
								
									
									The 1,4-naphthoquinones interact moderately into a positive electrostatic pocket of human serum albumin (site I) via ground-state association.
									Luis Guilherme A. do Nascimento 
; Maike F. S. Barbetta 
; Otávio A. Chaves 
; Anderson R. M. de Oliveira 
; Sofia Nikolaou
								
									
									[Ru3O(CH3COO)5(py)2(dppzCl)]PF6 (py = pyridine; dppz-Cl = 7-chlorodipyrido[3,2-a:2',3'-c]phenazine) is metabolized by human cytochrome P450 enzymes when incubated with human liver microsomes.
Online version ISSN 1678-4790 Printed version ISSN 0103-5053 
 Journal of the Brazilian Chemical Society 
 JBCS Editorial and Publishing Office 
 University of Campinas - UNICAMP 
 13083-970 Campinas-SP, Brazil 
                    
 Free access